Literature DB >> 20452835

Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians.

Razmic S Gregorian1, Alexander Gasik, Winghan Jacqueline Kwong, Simon Voeller, Shane Kavanagh.   

Abstract

UNLABELLED: This study examined the relative impact of pain relief and opioid side effects on patients' and physicians' preferences for medication. An Internet survey was completed by 618 patients (302 acute pain, 316 chronic pain) and 325 physicians (83 primary care, 80 pain specialists, 41 oncologists, 40 general surgeons, 40 orthopedic surgeons, 20 rheumatologists, 21 neurologists). Respondents completed an Adaptive Conjoint Analysis (ACA) exercise in which they indicated their relative preference for 20 pairs of hypothetical opioid pain medications described by varying levels of pain relief and side-effect incidence. Almost all patients (96% of chronic, 92% of acute) reported experiencing at least 1 side effect while on opioid medication, but physician-estimated incidence rates of most opioid side effects were much lower than those reported by patients. Opioid side effects, rather than pain relief, explained the majority of variance for medication preference for both patients (74% for chronic, 73% for acute) and treating physicians (73% for chronic, 74% for acute) in this exercise. Nausea and vomiting were major determinants of opioid medication preference, with each explaining as much of the variance in preference as did pain relief (21% to 25%). Nausea and vomiting were the most important side effects based on the amount of pain relief that respondents were willing to give up for reducing the incidence of side effects. The importance of side effects was confirmed in an open-ended question where 51% of patients and 58% of physicians identified side-effect reduction as an unmet need for pain medications. PERSPECTIVE: This study provided insights into patient and physician preferences of the risk and benefit balance of opioid therapy. This information could improve understanding of patient needs and facilitate the incorporation of patient preference into therapy choice.
Copyright © 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452835     DOI: 10.1016/j.jpain.2010.02.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  38 in total

Review 1.  The discovery and development of analgesics: new mechanisms, new modalities.

Authors:  Gillian Burgess; Dic Williams
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

2.  Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.

Authors:  Carlton D Dampier; Wally R Smith; Hae-Young Kim; Carrie Greene Wager; Margaret C Bell; Caterina P Minniti; Jeffrey Keefer; Lewis Hsu; Lakshmanan Krishnamurti; A Kyle Mack; Donna McClish; Sonja M McKinlay; Scott T Miller; Ifeyinwa Osunkwo; Phillip Seaman; Marilyn J Telen; Debra L Weiner
Journal:  Am J Hematol       Date:  2011-09-22       Impact factor: 10.047

3.  Comment on "Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?".

Authors:  Olfat Zekry; Charles A Inderjeeth
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

4.  Capsule Commentary on Merlin et al., Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study.

Authors:  M Barton Laws
Journal:  J Gen Intern Med       Date:  2018-02       Impact factor: 5.128

5.  Four Strategies for Managing Opioid-Induced Side Effects in Older Adults.

Authors:  Emma Rogers; Sonal Mehta; Rose Shengelia; Manney Carrington Reid
Journal:  Clin Geriatr       Date:  2013-04

6.  Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR.

Authors:  Xu Steven Xu; Mila Etropolski; David Upmalis; Akiko Okamoto; Rachel Lin; Partha Nandy
Journal:  Pharm Res       Date:  2012-05-23       Impact factor: 4.200

Review 7.  Opioid use in primary care: asking the right questions.

Authors:  Eleanor T Lewis; Jodie A Trafton
Journal:  Curr Pain Headache Rep       Date:  2011-04

8.  IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Authors:  Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen
Journal:  Clin Trials       Date:  2013-04       Impact factor: 2.486

9.  Shared decision-making in the selection of outpatient analgesics for older individuals in the emergency department.

Authors:  Cameron G Isaacs; Christine Kistler; Katherine M Hunold; Greg F Pereira; Mara Buchbinder; Mark A Weaver; Samuel A McLean; Timothy F Platts-Mills
Journal:  J Am Geriatr Soc       Date:  2013-04-16       Impact factor: 5.562

Review 10.  Discrete choice experiments in health economics: a review of the literature.

Authors:  Michael D Clark; Domino Determann; Stavros Petrou; Domenico Moro; Esther W de Bekker-Grob
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.